Shanghai Pulmonary Hospital

Shanghai, Shanghai Municipality, China

63 recruiting

Showing 120 of 118 trials

Recruiting
Phase 3

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Bronchiectasis
Boehringer Ingelheim1,755 enrolled470 locationsNCT06872892
Recruiting
Phase 3

Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)

Small Cell Lung Cancer
Amgen400 enrolledNCT07778316
Recruiting
Phase 3

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Non-small Cell Lung Cancer
Boehringer Ingelheim400 enrolled199 locationsNCT07195695
Recruiting
Phase 1Phase 2

A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors

Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.201 enrolled1 locationNCT06605222
Recruiting
Phase 3

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

Extensive-stage Small Cell Lung Cancer (ES-SCLC)Small Cell Lung Cancer ( SCLC )
Boehringer Ingelheim670 enrolled242 locationsNCT07472517
Recruiting

T2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPD

AsthmaCOPD, Chronic Obstructive Pulmonary Disease
Shanghai Pulmonary Hospital, Shanghai, China538 enrolledNCT07823842
Recruiting
Phase 1Phase 2

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

Advanced Solid TumorMalignant MesotheliomaMetastatic Malignant Solid Tumor
InSilico Medicine Hong Kong Limited160 enrolled10 locationsNCT06566079
Recruiting
Phase 1

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

Advanced Solid Tumor
BeOne Medicines525 enrolled98 locationsNCT06589596
Recruiting
Phase 1

A Study of BG-C477 in Participants With Advanced Solid Tumors

Advanced Solid Tumors
BeOne Medicines310 enrolled54 locationsNCT06596473
Recruiting
Phase 1

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Advanced Solid TumorSolid Tumor
BeOne Medicines337 enrolled28 locationsNCT05981703
Recruiting
Phase 3

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

Small Cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd.480 enrolled76 locationsNCT07218146
Recruiting
Phase 1

Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers

Advanced cancers
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.42 enrolled11 locationsNCT07260708
Recruiting
Phase 1Phase 2

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Non-small Cell Lung Cancer
Hoffmann-La Roche320 enrolled71 locationsNCT05789082
Recruiting

Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy

Carcinoma, Non-Small Cell Lung
Hoffmann-La Roche800 enrolled44 locationsNCT06862869
Recruiting
Phase 3

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-small Cell Lung CancerKRAS G12C Lung Cancer
Hoffmann-La Roche600 enrolled260 locationsNCT06793215
Recruiting
Phase 2

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.48 enrolledNCT07512596
Recruiting
Phase 2

Phase II Study of RC1416 Injection in COPD

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Nanjing RegeneCore Biotech Co., Ltd.180 enrolled42 locationsNCT07402551
Recruiting

Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer

NSCLC (Non-small Cell Lung Cancer)
Betta Pharmaceuticals Co., Ltd.2,572 enrolledNCT07806604
Recruiting
Phase 1Phase 2

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

Advanced Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.465 enrolled38 locationsNCT07367529
Recruiting
Phase 1Phase 2

A Study of ZL-1310 in Participants With Selected Solid Tumors

Solid Tumors
Zai Lab (Shanghai) Co., Ltd.166 enrolled23 locationsNCT06885281